%20(1).svg)
Serán Discusses Small Molecules, IRA and Innovation with Biospace's Lori Ellis
"The IRA: A Catalyst for Societal Change"
Published: Feb 07, 2024
By Lori Ellis, Head of Biospace Insights
Working together to bring advanced, affordable and effective medicines to patients is a shared goal in the pharma industry. Serán BioScience's CEO Dan Smithey, PhD discusses innovation, small molecules and the IRA with Lori Ellis, Head of Insights for Biospace.
Read the article on Biospace.
About Serán
Serán BioScience, LLC, is a science-driven drug development partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, email us at hello@seranbio.com.
Contact
Brinette Holdren
Director of Marketing
Serán BioScience, LLC
63047 Layton Ave,
Bend, OR 97701 USA
Phone: (541)-237-8501
www.seranbio.com
.svg)